CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($) $ in Thousands	Total	ATM facility	Tempus Investment Agreement	Common Stock	Common Stock ATM facility	Common Stock Tempus Investment Agreement	Additional Paid-In Capital	Additional Paid-In Capital ATM facility	Additional Paid-In Capital Tempus Investment Agreement	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance at Dec. 31, 2023	$ 129,441			$ 5			$ 598,364			$ (222)	$ (468,706)
Beginning balance, shares at Dec. 31, 2023				50,480,694
Exercise of Tempus Warrants	46,739			$ 1			46,738
Exercise of Tempus Warrants, Shares				9,218,800
Proceeds from sales of common stock under, net		$ 30,078	$ 16,605		$ 1			$ 30,077	$ 16,605
Proceeds from sales of common stock, net, shares					6,660,731	3,500,000
Proceeds from ESPP	317						317
Proceeds from ESPP, shares				391,415
Restricted stock units vested, shares				340,079
Proceeds from exercise of stock options	114						114
Proceeds from exercise of stock options, shares				46,471
Stock-based compensation	8,017						8,017
Foreign currency translation adjustment	233									233
Unrealized gain on available-for-sale debt securities	76									76
Net loss	(64,859)										(64,859)
Ending balance at Sep. 30, 2024	166,761			$ 7			700,232			87	(533,565)
Ending balance, shares at Sep. 30, 2024				70,638,190
Beginning balance at Jun. 30, 2024	112,272			$ 5			606,863			(120)	(494,476)
Beginning balance, shares at Jun. 30, 2024				53,052,847
Exercise of Tempus Warrants	46,739			$ 1			46,738
Exercise of Tempus Warrants, Shares				9,218,800
Proceeds from sales of common stock under, net		27,236	$ 16,605		$ 1			27,235	$ 16,605
Proceeds from sales of common stock, net, shares					4,760,588	3,500,000
Restricted stock units vested, shares				59,484
Proceeds from exercise of stock options	114						114
Proceeds from exercise of stock options, shares				46,471
Stock-based compensation	2,677						2,677
Foreign currency translation adjustment	61									61
Unrealized gain on available-for-sale debt securities	146									146
Net loss	(39,089)										(39,089)
Ending balance at Sep. 30, 2024	166,761			$ 7			700,232			87	(533,565)
Ending balance, shares at Sep. 30, 2024				70,638,190
Beginning balance at Dec. 31, 2024	202,957			$ 9			752,961			(23)	(549,990)
Beginning balance, shares at Dec. 31, 2024				85,171,146
Proceeds from sales of common stock under, net		$ 17,782						$ 17,782
Proceeds from sales of common stock, net, shares					3,064,152
Proceeds from ESPP	624						624
Proceeds from ESPP, shares				193,738
Restricted stock units vested, shares				197,819
Proceeds from exercise of stock options	274						274
Proceeds from exercise of stock options, shares				118,511
Stock-based compensation	7,131						7,131
Foreign currency translation adjustment	66									66
Unrealized gain on available-for-sale debt securities	39									39
Net loss	(57,458)										(57,458)
Ending balance at Sep. 30, 2025	171,415			$ 9			778,772			82	(607,448)
Ending balance, shares at Sep. 30, 2025				88,745,366
Beginning balance at Jun. 30, 2025	190,829			$ 9			776,596			20	(585,796)
Beginning balance, shares at Jun. 30, 2025				88,649,766
Restricted stock units vested, shares				55,506
Proceeds from exercise of stock options	94						94
Proceeds from exercise of stock options, shares				40,094
Stock-based compensation	2,082						2,082
Foreign currency translation adjustment	(33)									(33)
Unrealized gain on available-for-sale debt securities	95									95
Net loss	(21,652)										(21,652)
Ending balance at Sep. 30, 2025	$ 171,415			$ 9			$ 778,772			$ 82	$ (607,448)
Ending balance, shares at Sep. 30, 2025				88,745,366